4//SEC Filing
MILLER GEORGE LLOYD 4
Accession 0001562180-20-006600
CIK 0000105770other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 6:36 PM ET
Size
13.0 KB
Accession
0001562180-20-006600
Insider Transaction Report
Form 4
MILLER GEORGE LLOYD
Sr. VP, GC & Corp. Sec.
Transactions
- Sale
Common Stock
2020-11-06$297.28/sh−2,658$790,179→ 7,540.298 total - Exercise/Conversion
Common Stock
2020-11-06$62.30/sh+9,000$560,700→ 16,540.298 total - Sale
Common Stock
2020-11-06$296.41/sh−6,342$1,879,862→ 10,198.298 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-06−7,860→ 0 totalExercise: $62.30From: 2015-11-19Exp: 2025-11-19→ Common Stock (7,860 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-06−1,140→ 14,584 totalExercise: $62.30From: 2016-02-23Exp: 2025-11-19→ Common Stock (1,140 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $295.88 to $8296.73, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $296.91 to $297.70, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001472382
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 6:36 PM ET
- Size
- 13.0 KB